These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34222869)

  • 21. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.
    Strang KH; Croft CL; Sorrentino ZA; Chakrabarty P; Golde TE; Giasson BI
    J Biol Chem; 2018 Feb; 293(7):2408-2421. PubMed ID: 29259137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies.
    Annadurai N; De Sanctis JB; Hajdúch M; Das V
    Exp Neurol; 2021 Sep; 343():113756. PubMed ID: 33989658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo.
    Vasconcelos B; Stancu IC; Buist A; Bird M; Wang P; Vanoosthuyse A; Van Kolen K; Verheyen A; Kienlen-Campard P; Octave JN; Baatsen P; Moechars D; Dewachter I
    Acta Neuropathol; 2016 Apr; 131(4):549-69. PubMed ID: 26739002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly Specific and Sensitive Target Binding by the Humanized pS396-Tau Antibody hC10.2 Across a Wide Spectrum of Alzheimer's Disease and Primary Tauopathy Postmortem Brains.
    Helboe L; Rosenqvist N; Volbracht C; Pedersen LØ; Pedersen JT; Christensen S; Egebjerg J; Christoffersen CT; Bang-Andersen B; Beach TG; Serrano GE; Falsig J
    J Alzheimers Dis; 2022; 88(1):207-228. PubMed ID: 35570492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies.
    Leroux E; Perbet R; Caillierez R; Richetin K; Lieger S; Espourteille J; Bouillet T; Bégard S; Danis C; Loyens A; Toni N; Déglon N; Deramecourt V; Schraen-Maschke S; Buée L; Colin M
    Mol Ther; 2022 Feb; 30(2):782-797. PubMed ID: 34563677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperacetylation mimetics within the tau filament core inhibits prion-like propagation of misfolded tau.
    Smith ED; McKenna R; Mietzsch M; Borchelt DR; Prokop S; Chakrabarty P
    bioRxiv; 2024 Apr; ():. PubMed ID: 38659970
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Ingham DJ; Hillyer KM; McGuire MJ; Gamblin TC
    Biochemistry; 2022 Jul; 61(13):1243-1259. PubMed ID: 35731895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloidogenesis of Tau protein.
    Nizynski B; Dzwolak W; Nieznanski K
    Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tau R2 and R3 are essential regions for tau aggregation, seeding and propagation.
    Annadurai N; Malina L; Malohlava J; Hajdúch M; Das V
    Biochimie; 2022 Sep; 200():79-86. PubMed ID: 35623497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of a conformational antibody that binds tau oligomers and inhibits pathological seeding by extracts from donors with Alzheimer's disease.
    Abskharon R; Seidler PM; Sawaya MR; Cascio D; Yang TP; Philipp S; Williams CK; Newell KL; Ghetti B; DeTure MA; Dickson DW; Vinters HV; Felgner PL; Nakajima R; Glabe CG; Eisenberg DS
    J Biol Chem; 2020 Jul; 295(31):10662-10676. PubMed ID: 32493775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined Model of Aggregation and Network Diffusion Recapitulates Alzheimer's Regional Tau-Positron Emission Tomography.
    Raj A; Tora V; Gao X; Cho H; Choi JY; Ryu YH; Lyoo CH; Franchi B
    Brain Connect; 2021 Oct; 11(8):624-638. PubMed ID: 33947253
    [No Abstract]   [Full Text] [Related]  

  • 33. Monoclonal antibody Y01 prevents tauopathy progression induced by lysine 280-acetylated tau in cell and mouse models.
    Song HL; Kim NY; Park J; Kim MI; Jeon YN; Lee SJ; Cho K; Shim YL; Lee KH; Mun YS; Song JA; Kim MS; Pack CG; Jung M; Jang H; Na DL; Hong M; Kim DH; Yoon SY
    J Clin Invest; 2023 Apr; 133(8):. PubMed ID: 36917188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Sterilization Methods on the Seeding Ability of Human Tau Proteopathic Seeds.
    Fernandes AR; Dujardin S; Maté de Gérando A; Hyman BT; Frosch MP
    J Neuropathol Exp Neurol; 2021 Oct; 80(10):912-921. PubMed ID: 34498073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The chaperone Clusterin in neurodegeneration-friend or foe?
    Yuste-Checa P; Bracher A; Hartl FU
    Bioessays; 2022 Jul; 44(7):e2100287. PubMed ID: 35521968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasal Extracts from Patients with Alzheimer's Disease Induce Tau Aggregates in a Cellular Model of Tau Propagation.
    Pahrudin Arrozi A; Yanagisawa D; Kato T; Akatsu H; Hashizume Y; Kaneda D; Tooyama I
    J Alzheimers Dis Rep; 2021 Apr; 5(1):263-274. PubMed ID: 34113783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulating disease-relevant tau oligomeric strains by small molecules.
    Lo Cascio F; Garcia S; Montalbano M; Puangmalai N; McAllen S; Pace A; Palumbo Piccionello A; Kayed R
    J Biol Chem; 2020 Oct; 295(44):14807-14825. PubMed ID: 32737202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time- and dose-dependent seeding tendency of exogenous tau R2 and R3 aggregates in cells.
    Annadurai N; Hrubý J; Kubíčková A; Malina L; Hajdúch M; Das V
    Biochem Biophys Res Commun; 2023 Apr; 653():102-105. PubMed ID: 36863211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytosolic condensates rich in polyserine define subcellular sites of tau aggregation.
    Lester E; Van Alstyne M; McCann KL; Reddy S; Cheng LY; Kuo J; Pratt J; Parker R
    Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2217759120. PubMed ID: 36626563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prion-like Spreading in Tauopathies.
    Ayers JI; Giasson BI; Borchelt DR
    Biol Psychiatry; 2018 Feb; 83(4):337-346. PubMed ID: 28506438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.